We know for a fact that some hedge funds have hired investigators to try to find out if patients were helped by clinical trial drugs. There are cases in which health care personnel and even janitors were asked questions and, they said, offered bribes. We know that investigators have figured out names of patients (easy enough to do: observe the site, see who's going in for infusions, get their license plate number) and tried to befriend them, or look at their Facebook page to see how they are feeling, if they're going out and doing stuff or lying home sick, etc.

That's why the shorts were so frantic to try to find the trial location of Brilacidin-UP, and now of Kevetrin.

And we also know, as Popperian pointed out, that sometimes these scum try to interfere with the trials. PRAN's novel and very promising Alzheimer's drug "failed" because the drug's effect was about the same as placebo. The only thing was -- the placebo group's result was far, far higher than past studies would have indicated was possible. So, many of us think that someone messed with the data to make the drug appear not to work, when in fact it did.

There have been other similar stories. And I still wonder about the "non-compliance" at the one CTIX clinical trial site, which got very different results from all the other sites because of "investigator non-compliance." Kinda makes you understand "why the secrecy," doesn't it?